AMERICAN CENTURY COMPANIES INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 748054
KANSAS CITY, MO
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$363,164,283
-$21,574,694 QoQ
Shares Held
813,285
-4.2% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92.67341706781755.ToString("F0")%
Shared 7.326582932182444.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,311,104 across 169 Biotechnology names. VRTX ranks #3 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $363,164,283 | 813,285 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $384,738,977 | 848,639 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $175,921,946 | 449,193 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $239,576,366 | 538,132 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $225,800,551 | 465,741 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $190,622,072 | 473,360 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $225,476,830 | 484,813 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $274,820,847 | 586,322 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $290,472,640 | 694,894 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $325,730,499 | 800,537 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $352,413,231 | 1,001,430 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $362,614,693 | 1,150,902 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $326,614,511 | 1,131,015 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $364,848,485 | 1,260,097 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $332,380,885 | 1,179,534 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $287,295,348 | 1,100,875 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $137,129,878 | 624,453 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $139,580,693 | 769,506 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $181,519,423 | 900,260 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $154,115,884 | 717,185 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $220,229,174 | 931,832 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $279,785,076 | 1,028,168 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $236,112,897 | 813,313 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $261,564,395 | 1,099,241 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||